Evidence map›Paper›PMID 40192450›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Continuous Flow Synthesis of Nitrofuran Pharmaceuticals Using Acetyl Nitrate.

Hubert Hellwig, Loïc Bovy, Kristof Van Hecke, Cornelis P Vlaar, Rodolfo J Romañach, Md Noor-E-Alam, Allan S Myerson, Torsten Stelzer, Jean-Christophe M Monbaliu

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Continuous Flow Synthesis of Nitrofuran Pharmaceuticals Using Acetyl Nitrate.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hubert HellwigCenter for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, B6a, Room 3/19, Allée du Six Août 13, Liège (Sart Tilman), B-4000, Belgium.
Loïc BovyCenter for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, B6a, Room 3/19, Allée du Six Août 13, Liège (Sart Tilman), B-4000, Belgium.
Kristof Van HeckeDepartment of Inorganic and Physical Chemistry, Ghent University, Krijgslaan 281-S3, Ghent, B-9000, Belgium.
Cornelis P VlaarDepartment of Pharmaceutical Sciences, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, 00936, USA.
Rodolfo J RomañachDepartment of Chemistry, University of Puerto Rico - Mayagüez, Mayagüez, PR, 00681, USA.
Md Noor-E-AlamDepartment of Mechanical and Industrial Engineering, College of Engineering, Center for Health Policy and Healthcare Research, Northeastern University, Boston, MA, 02115, USA.
Allan S MyersonDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Torsten StelzerDepartment of Pharmaceutical Sciences, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, 00936, USA.
Jean-Christophe M MonbaliuCenter for Integrated Technology and Organic Synthesis (CiTOS), MolSys Research Unit, University of Liège, B6a, Room 3/19, Allée du Six Août 13, Liège (Sart Tilman), B-4000, Belgium.

Funding

Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) CÉCI 2.5020.11Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) MIS F453020FSpecial Research Fund (BOF) - UGent BOF/24J/2023/084U.S. Food and Drug Administration BAA-22-00123 program 75F40122C00192
6 · The paper itself

Abstract

Nitrofurfural is a key building block for the synthesis of antimicrobial nitrofurans as active pharmaceutical ingredients. Its synthesis involves the nitration of furfural, a substrate derived from biobased resources. However, furfural has a delicate heteroaromatic backbone. Typical nitrations involve harsh reaction conditions, which often compromise this structure, resulting in poor reproducibility and low yields. Although acetyl nitrate, a mild nitrating agent, is suitable for this task, major deterrents remain. First, its conventional preparation method involves conditions that are not compatible with furfural. Second, significant safety concerns are associated with the unstable and explosive nature of acetyl nitrate. These critical issues are addressed herein. A safe and robust continuous flow platform featuring in situ generation of acetyl nitrate for the nitration of furfural to nitrofurfural is reported. The high level of integration and automation enables remote process operation by a single operator. Key furfural-based pharmaceutical intermediates were synthesized with favorable metrics and high reproducibility. The efficiency of this flow platform is demonstrated using a selection of best-selling nitrofuran pharmaceuticals (nifuroxazide, nifurtimox, nitrofurantoin, and nitrofural), which were obtained with excellent isolated yields in under five minutes.

Indexed as

NitratesNitrofuransFuraldehydeMolecular StructureFuraldehydeNitratesNitrofuransFlow chemistryFurfuralNitration platformsNitrofuransProcess analytical technology

Identifiers

PMID40192450
PMCPMC12171659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.